Search for new drugs: Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)

Pharmaceutical Chemistry Journal

Volumn 43, Issue 10, 2009, Pages 539-548

  Baltina, L A ^a   Kondratenko, R M ^b   Baltina Jr , L A ^a   Plyasunova, O A ^c   Pokrovskii, A G ^c   Tolstikov, G A ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

^b BASHKIR STATE MEDICAL UNIVERSITY   (Russian Federation)

^c STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

Author keywords

Antiviral activity; Antiviral drugs; Biologically active nutrient additives; Glycyrrhizic acid; Licorice root

Indexed keywords

EID: 84859389689     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-010-0348-2     Document Type: Article

References (212)

1. F. I. Ershov, Antiviral Preparations [in Russian], Meditsina, Moscow (1998).
2. F. I. Ershov and N. V. Kas'yanova, Consilium Medicum, 6 (1) (2004); http://www.consilium-medicum.com.
3. G. Matthee, A. D. Wright, and G. M. Konig, PlantaMed., 65(6), 493-506 (1999).
4. J. W. Corbett, Curr Med. Chem.: Anti Infect. Agents, 1(2), 119-140 (2003).
5. T. Imamichi, Front. Med. Chem., 3, 23-44 (2006).
6. P. Domingo, F. Vidal, and J. C. Domingo, Curr. Med. Chem.: Anti Infect. Agents, 3(2), 109-133 (2004).
7. V. K. Tandon and R. B. Chhor, Curr. Med. Chem.: Anti Infect. Agents, 4(1), 3-28 (2005).
8. V. P. Fisenko, A. P. Drozhzhin, and M. T. Abidov, Analysis of the Most Promising Research on the Creation of New Drugs [in Russian], NTsEGKLS, Moscow (2000).
9. Russian Therapeutic Handbook [in Russian], GEOTAR-Media, Moscow (2005).
10. M. D. Mashkovskii, Drugs [in Russian], Novaya Volna, Moscow (2000).
11. R. Manfredi and S. Sabbatani, Curr. Med. Chem., 13(20), 2369-2384 (2006).
12. C. Balsano and A. Alisi, Curr. Med. Chem., 15(9), 930-939 (2008).
13. A. M. Del Vecchio and R. T. Sarisky, Mini-Reviews Med. Chem., 6(11), 1263-1268 (2006).
14. K. Matsuo, K. Takenaka, H. Shimomura, et al., Leuk. Lymphoma, 41, 191-195 (2001).
15. M. S. Butler, J. Nat. Prod., 67(12), 2141-2153 (2004).
16. M. S. Butler, Nat. Prod. Res., 22, 162-195 (2005).
17. Vidal Handbook. Drugs in Russia: Handbook [in Russian], AstraFarmServis, Moscow (2005).
18. Encyclopedia of Drugs [in Russian], OOO RLS-2005, Moscow (2004).
19. V. M. Salo, Man's Green Friends [in Russian], Nauka, Moscow (1975).
20. B. G. Volynskii, K. I. Bender, S. L. Freidman, et al., Medicinal Plants in Scientific and Folk Medicine [in Russian], Izd. Saratov. Univ., Saratov (1972).
21. G. A. Tolstikov, E. E. Shul'ts, L. A. Baltina, and T. G. Tolstikova, Khim. Interesakh Ustoich. Razvit., No. 5, 57-73 (1997).
22. Study and Use of Licorice in the USSR Economy [in Russian], Gylym, Alma-Ata (1991).
23. A. I. Isambaev, B. N. Saurambaev, E. V. Kuz'min, and M. K. Kukenov, Licorice - A Valuable Medicinal-Industrial Plant Indigenous to Kazakhstan [in Russian], Alma-Ata (1991).
24. V. P. Grankina and G. P. Nadezhina, Ural Licorice [in Russian], Nauka, Sib. Br., Novosibirsk (1991).
25. S. A. Vichkanovanad M. A. Rubinchik, Licorice Root [in Russian], Meditsina, Moscow (1978).
26. E. A. Kurganova, Tr. BIN Akad. Nauk SSSR, Ser. 1, No. 11, 164-167 (1995).
27. E. A. Kurganova, Problems of the Study and Use of Licorice in the USSR Economy [in Russian], Nauka, Moscow-Leningrad (1966), pp. 19-26.
28. I. A. Murav'ev and V. S. Sokolov, Problems of the Study and Use of Licorice in the USSR Economy [in Russian], Nauka, Moscow-Leningrad (1966), pp. 5-14.
29. E. V. Kucherov, D. N. Lazareva, and V. K. Desyatkin, Medicinal Plants of Bashkiria: Their Use and Protection [in Russian], Bashkir. Knizhnoe Izd., Ufa (1990).
30. Rare and Threatened Species of the USSR Flora Needing Protection [in Russian], Nauka, Leningrad (1990).
31. S. Ya. Sokolov and I. P. Zamotaev, Handbook of Medicinal Plants [in Russian], Meditsina, Moscow (1988).
32. A. S. Ammosov, V. V. Timofeeva, and V. I. Litvinenko, Rastit. Resur., 20(2), 248-251 (1984).
33. USSR State Pharmacopoeia, USSR Min. Health, XI Ed., Vneshtorgizdat, Moscow (1991).
34. A. F. Lebeda, N. I. Dzhurenko, A. P. Isaikina, and V. G. Sobko, Medicinal Plants: A Complete Encyclopedia [in Russian], AST-PRESS KNIGA, Moscow (2004).
35. USSR State Pharmacopoeia, USSR, Min. Health, Xth Ed., Meditsina, Moscow (1987), pp. 24-31 (1999).
36. I. A. Muravev, Farm. Pol., 23(7-8), 798-803 (1967).
37. A. S. Ammosov, V. I. Litvinenko, and T. P. Popova, Gos. NII Ekon. Med. Prom'st, No. 1, 1-9 (1998).
38. I. A. Murev'ev and A. K. Tsaturyan, Current Problems in Pharmacy [in Russian], Alma-Ata (1989), pp. 88-89.
39. G. A. Statti, R. Tundis, G. Sacchetti, et al., Fitoterapia, 75(3-4), 371-374 (2004).
40. H. Hayashi, S. Hattori, K. Inoue, et al., Chem. Pharm. Bull., 51(11), 1338-1340 (2003).
41. A. S. Ammosov and V. I. Litvinenko, Rastit. Resur., 31(3), 116-145 (1995).
42. A. S. Ammosov and V. I. Litvinenko, Khim.-farm. Zh., 37(2), 31-42 (2003).
43. V. P. Georgievskii, N. F. Komissarov, and S. E. Dmitruk, Biologically Active Compounds from Medicinal Plants [in Russian], Nauka, Novosibirsk (1990).
44. V. E. Tyler, Pharmacognosy, 9th Ed., Len & Febiger, Philadelphia (1988).
45. S. Shibata, J. Pharm. Soc. Jpn., 120(10), 849-862 (2000).
46. I. Kitagawa, Pure Appl. Chem., 74(7), 1189-1198 (2002).
47. G. V. Obolentseva, V. I. Litvinenko, and A. S. Ammosov, Khim.-farm. Zh., 33(8), 24-31 (1999).
48. G. A. Tolstikov, L. A. Baltina, E. E. Shul'ts, and A. G. Pokrovskii, Bioorg. Khim., 23(9), 691-709 (1997).
49. G. A. Tolstikov and M. I. Goryaev, Glycyrrhetic Acid [in Russian], Nauka, Alma-Ata (1966).
50. G. A. Tolstikov, L. A. Baltina, and N. G. Serdyuk, Khim.-farm. Zh., 32(8), 5-14 (1998).
51. H. A. V. Hartung, USA Pat. No. 4, 176, 228, Nov. 27, 1979;
52. Chem. Abstr., 92, 145286g (1980).
53. L. M. Khalilov, L. A. Baltina, L. V. Spirikhin, et al., Khim. Prir. Soedin., No. 4, 500-505 (1989).
54. L. A. Baltina, O. Kunert, A. A. Fatykhov, et al., Khim. Prir. Soedin., 4, 347-350 (2005).
55. G. A. Tolstikov and M. P. Irismetov, Izv. Akad. Nauk Kaz. SSR, Ser. Khim., No. 4, 53-61 (1984).
56. E. V. Buranova, U. A. Turumbetov, and S. M. Adekenov, Phytochemistry for Development of the Pharmacy Industry, Proceedings of a Republic Scientific-Practical Conf. Dedicated to the 60-th Birthday of Famous Scientist M. N. Mukhametzhanov [in Russian], Karaganda (2000), pp. 236-238.
57. World Health Organization, Radix Glycyrrizae Monographs on Selected Medicinal Plants, Vol. 1, Geneva (1999), pp. 183-194.
58. G. J. Kapadia, M. A. Azune, H. Tokuda, et al., Pharmacol. Res., 45(3), 213-220 (2002).
59. J. T. Coon and E. Ernst, J. Hepatol., 40(3), 491-500 (2004).
60. L. Badam, J. Commun. Diseas., 29(2), 91-99 (1997).
61. J. Bradbury, Lancet. Infect. Dis., 5(4), 201 (2005).
62. E. S. Mirza-zade and N. S. Nagieva, http://interstom.narod.ru/solodka. html.
63. R. Pompei, Riv. Farmacol. Ter, 10(3), 281-284 (1979).
64. R. Pompei, A. Pani, O. Flore, et al., Experientia, 36(3), 304 (1980).
65. R. Pompei, O. Flore, A. Pani, et al., Riv. Farmacol. Ter, 10(4), 355-359 (1979).
66. R. Pompei, O. Flore, M. Marcialis, et al., Nature (London), 281(5733), 689-690 (1979).
67. R. Pompei, L. Paghi, A. Ingianni, and P. Uccheddu, Microbiologica, 6(3), 247-250 (1983).
68. R. Pompei, Riv. Farmacol. Ter, 12(1), 43-46 (1981).
69. M. Baba and S. Shigeta, Antiviral Res., 7(2), 99-107 (1987).
70. L. Badam, Nat. Med. J. India, 10(2), 98 (1997).
71. T. Utsunomiya, M. Kobayashi, D. N. Herndon, et al., Immunol. Lett., 44, 59-66 (1995).
72. C. Ceremelli, M. Portolani, B. Cotombari, et al., Phytochem. Res., 10, 527-528 (1996).
73. K. Numazaki, N. Nagata, T. Sato, and S. Chiba, J. Leukocyte Biol., 55, 24-28 (1994).
74. J.-M. Crance, F. Leveque, E. Biziagos, et al., Antiviral Res., 23, 63-76 (1994).
75. H. Sato, W. Goto, J.-I. Yamamura, et al., Antiviral Res., 30, 171-177 (1996).
76. Y. Arase, K. Ikeda, N. Murashima, et al., Cancer, 79(8), 1494-1500 (1997).
77. J.-C. Lin, Antiviral Res., 59, 41-47 (2003).
78. J. Cinatl, B. Morgenstern, G. Bauer, et al., Lancet, 361(6), 2045-2046 (2003).
79. M. Ito, H. Nakashima, N. Yamamoto, et al., Eur. Pat. No. 255, 420 (1988);
80. Chem. Abstr, 109, 116062v (1988).
81. M. Ito, H. Nakashima, M. Baba, et al., Jpn. Pat. Appl., No. 63-3332 (1988);
82. Ref. Zh. Khim., 6 O 209P (1989).
83. M. Ito, Jikken Igaku, 7(7), 858-860 (1989);
84. Chem. Abstr, 111, 49739x (1989).
85. M. Ito, H. Nakashima, M. Baba, et al., Antiviral Res., 7(3), 127-137 (1987).
86. E. De Clerq, Trends Pharmacol. Sci., 8(9), 339-345 (1987).
87. M. Ito, H. Nakashima, M. Baba, et al., Igaku no Ayumi, 141(7), 427-428 (1987);
88. Chem. Abstr, 107, 89374y (1987).
89. E. De Clerq, Med. Res. Rev., 20(5), 323-349 (2000).
90. E. De Clerq, J. Med. Chem., 38(14), 2491-2517 (1995).
91. A. J. Vlietinck, T. De Bruyne, S. Apers, and L. A. Pieters, PlantaMed., 64, 97-109 (1998).
92. M. Ito, A. Sato, K. Hirabayashi, et al., Antiviral Res., 10(6), 289-298 (1988).
93. R. Ueno, R. Ueno, and S. Kuno, Eur. Pat. No. 312, 222, Apr. 19, 1989;
94. Chem. Abstr, 112, 84180a (1990).
95. O. A. Plyasunova, Candidate Dissertation in Biological Sciences as a Scientific Paper, Kol'tsovo (1992).
96. T. Hattori, S. Ikumatsu, A. Koivo, et al., Antiviral Res., 11(5-6), 255-261 (1989).
97. N. Ikegami, S. Kinoshita, T. Kanesaki, K. Uno, K. Akatani, and T. Kishida, Antiviral Res., 30(1), A33 (1996).
98. O. A. Plyasunova, O. A. Mamaeva, N. M. Gashnikova, et al., VICh/SPID Rodstv. Probl., 3(1), 58 (1999).
99. O. A. Plyasunova, I. N. Egoricheva, N. V. Fedyuk, et al., Vopr. Virusol., No. 5-6, 235-238 (1992).
100. K. Miyamoto, T. Okuda, and K. Hirabayashi, Jpn. Pat. No. 02304024, Dec. 17, 1990;
101. Chem. Abstr., 115, 41976j (1991).
102. T. S. Tochikura, H. Nakashima, and N. Yamamoto, J. Acquired Immune Defic. Syndr., No. 2, 441-447 (1989).
103. Y. Isowa, Y. Sato, Y. Nakajima, and N. Yamamoto, Jpn. Pat. No. 63243093, Oct. 7, 1988;
104. Chem. Abstr., 111, P58268v (1989).
105. D. Yasiro and M. Matida, Jpn. Pat. Appl. No. 1-238525 (1989);
106. Ref. Zh. Khim., 5 O 258P (1990).
107. S. Saito, T. Furumoto, M. Ochiai, et al., Eur. J. Med. Chem., 31, 365-381 (1996).
108. K. Hirabayashi, S. Iwata, H. Matsumoto, et al., Chem. Pharm. Bull., 39(1), 112-115 (1991).
109. G. A. Tolstikov, L. A. Baltina, S. A. Ryzhova, et al., Abstracts of Comm. of International Conf. on Molecular Biology Aspects of Diagnostics and Therapy of AIDS, Academgorodok, Novosibirsk (1991), p. 14.
110. G. A. Tolstikov, L. A. Baltina, A. G. Pokrovskii, et al., RF Pat. No. 2, 024, 544 (1991);
111. Byull. Izobret., NO. 23 (1994).
112. L. A. Baltina, A. G. Pokrovskii, O. A. Plyasunova, and G. A. Tolstikov, RF Pat. No. 2, 024, 542 (1991);
113. Byull. Izobret., No. 23 (1994).
114. G. A. Tolstikov, L. A. Baltina, A. G. Pokrovskii, et al., RF Pat. No. 2, 024, 546 (1991);
115. Byull. Izobret., No. 23 (1994).
116. G. A. Tolstikov, L. A. Baltina, A. G. Pokrovskii, et al., RF Pat. No. 2, 024, 545 (1991);
117. Byull. Izobret., No. 23 (1994).
118. L. A. Baltina, A. G. Pokrovskii, O. A. Plyasunova, and G. A. Tolstikov, RF Pat. No. 2, 024, 547 (1991);
119. Byull. Izobret., No. 23 (1994).
120. L. A. Baltina, A. G. Pokrovskii, O. A. Plyasunova, and G. A. Tolstikov, RF Pat. No. 2, 024, 543 (1991);
121. Byull. Izobret., No. 23 (1994).
122. R. M. Kondratenko, L. A. Baltina, S. R. Mustafina, et al., RF Pat. No. 2, 199, 547 (2001);
123. Byull. Izobret., No. 6 (2003).
124. R. M. Kondratenko, L. A. Baltina, O. A. Plyasunova, et al., RF Pat. No. 2, 198, 177 (2001);
125. Byull. Izobret., No. 4 (2003).
126. L. A. Baltina, Curr. Med. Chem., 10, No. 2, 155-171 (2003).
127. T. V. Il'ina, E. A. Semenova, O. A. Plyasunova, et al., Byull. Sib. Otd. Ross. Akad. Med. Nauk, No. 2, 20-24 (2002).
128. A. G. Pokrovskii, O. A. Plyasunova, T. N. Il'icheva, et al., Khim. Interesakh Ustoich. Razvit., No. 9, 485-491 (2001).
129. R. M. Kondratenko, L. A. Baltina, S. R. Mustafina, et al., Bioorg. Khim., 30, No. 3, 308-315 (2004).
130. L. A. Baltina, O. A. Plyasunova, A. G. Pokrovskii, et al., in: Abstracts of Papers of the Xth Russian Nat. Congr. Man and Medicine [in Russian], RTs Farmedinfo, Moscow (2003), p. 693.
131. A. G. Pokrovskii, O. A. Plyasunova, L. A. Baltina, et al., USSR Pat. No. 1, 804, 848;
132. Byull. Izobret., No. 12 (1993).
133. G. A. Tolstikov, L. A. Baltina, N. G. Serdyuk, et al., in: Abstracts of Papers of the IVth Russian Nat. Congr. Man and Medicine [in Russian], RTs Farmedinfo, Moscow (1997), p. 207.
134. O. A. Plyasunova, T. V. Il'ina, Ya. Yu. Kiseleva, et al., Vestn. Ross. Akad. Med. Nauk, No. 11, 42-46 (2004).
135. Kh. M. Nasyrov, Synthesis and Preclinical Study of New Biologically Active Compounds [in Russian], Coll. Sci. Works BGMI, Ufa (1988), pp. 49-54.
136. A. G. Pokrovskii, N. V. Fedyuk, S. M. Abdullaev, et al., RF Pat. Appl. No. 2003134868, Dec. 1, 2003.
137. Kh. M. Nasyrov, in: Abstracts of Papers of the 1st Russian Nat. Congr. Man and Medicine, RF Zdorov'e Cheloveka, Moscow (1992), p. 345.
138. Kh. M. Nasyrov, L. S. Chepurina, and R. M. Kireeva, Eksp. Klin. Farmakol., 58, No. 6, 60-63 (1995).
139. L. A. Baltina, N. A. Somov, N. G. Serdyuk, and G. A. Tolstikov, RF Pat. No. 2, 073, 009 (1997).
140. M. A. Mamon, Author's Abstract of a Candidate Dissertation in Medical Sciences, Moscow (1998).
141. A. G. Pokrovskii, E. F. Belanov, G. N. Volkov, et al., Dokl. Akad. Nauk, 344, No. 5, 709-711 (1995).
142. H. Hoever, L. Baltina, M. Michaelis, et al., J. Med. Chem., 48, No. 4, 1256-1259 (2005).
143. L. A. Baltina, R. M. Kondratenko, L. R. Mikhailova, et al., in: Abstracts of the XVIIIth Int. Symp. on Medicinal Chemistry, Copenhagen, Denmark & Malmo, Sweden (2004);
144. Drugs of the Future, 29(A), 86 (2004).
145. J. S. Baran, D. D. Langford, C. D. Liang, et al., J. Med. Chem., 17, 184-190 (1973).
146. D. J. Dargan and J. H. Subak-Sharpe, J. Gen. Virol, 66, 1771-1784 (1985).
147. D. E. Poswillo and G. J. Roberts, Lancet, 143-144 (1981).
148. S. Gottfried and L. Baxendale, Br. Pat. No. 843, 133 (1960);
149. Chem. Abstr, 55, 2027i (1960).
150. T. Gheorghiu, H. Frotz, and H. J. Klein, Verh. Dtsch. Ges. Inn. Med., 77, 511-515 (1971).
151. D. G. Colin-Jones, J. E. Lennard-Jones, J. H. Jones, et al., Symp. Carbenoxolone Sodium, Butterworths, London (1967);
152. I. Nakamura, Jpn. Pat. Appl. No. 61-165348 (1986);
153. Ref Zh. Khim., 16 O 125P (1987).
154. J. H. Baron and F. M. Sullivan, eds., Carbenoxolone Sodium, Butterworths, London (1970).
155. E. Shanbrom, US Pat. No. 5, 019, 495, May 28, 1991;
156. Chem. Abstr, 115, 202767j (1991).
157. E. Shanbrom, PCT Int. Pat. Appl., WO 9005533, May 31, 1990;
158. Chem. Abstr, 114, 88623m (1990).
159. P. A. Robe, F. Princen, D. Martin, et al., Biochem. Pharmacol, 60, 241-249 (2000).
160. M. Carrio, A. Mazo, C. Lopez-Iglesias, et al., Int. J. Cancer, 94, No. 1, 81-88 (2001).
161. D. J. Dargan and J. H. Subak-Sharpe, J. Gen. Virol, 67, 1831-1850 (1986).
162. A. G. Pokrovskii, O. A. Plyasunova, N. M. Gashnikova, et al., Vopr Virusol, 6, 38-42 (2001).
163. S. Harada, T. Maekawa, E. Haneda, et al., Biol. Pharm. Bull., 21(12), 1282-1285 (1998).
164. J.-M. Cheng, H.-J. Lin, Y.-H. Hsu, et al., Antiviral Res., 62, 27-36 (2004).
165. K. Ohtsuki and N. Iakida, Biochem. Biophys. Res. Commun., 157(2), 597-604 (1988).
166. K. Ohtsuki, S. Kanno, and N. Ishida, Igaku no Ayumi, 148(2), 113-114 (1989);
167. Chem. Abstr, 111, 17186y (1989).
168. A. Didkovskii, I. A. Zuikov, I. A. Malashenkova, A. N. Tanasova, and I. N. Shchepetkova, Rus. Med. Zh., 12 (7) (2004); online: http://www.rmj.ru/ articles 378.htm.
169. R. Pompei and M. A. Marcialis, I. Ig. Mod., 83, 385-391 (1985).
170. K. Ito, M. Miyata, M. Kosudo, et al., Igaku no Ayumi, 135(12/13), 1089-1090 (1985);
171. Chem. Abstr, 104, 161940n (1986).
172. I. Sugawara, S. Ishizaka, T. Tsuji, and M. De Ley, Nara Igaku Zasshi, 35(4), 424-429 (1984);
173. Chem. Abstr, 102, 11201k (1985).
174. Y. Feng and T. Zhu, Zhonghua Weishengwuxue He Mianyxue Zazhi, 6(2), 99-102 (1986);
175. Chem. Abstr, 105, 18041k (1986).
176. K. Kunano, T. Munakata, U. Semba, et al., Igaku no Ayumi, 129(3), 173-175 (1984);
177. Chem. Abstr., 101, 83711k (1984).
178. T. Sakuma, I. Voshida, M. Shinada, and H. Azuma, Igaku no Ayumi, 127(6), 669-671 (1983);
179. Chem. Abstr., 100, 66397z (1984).
180. Z. Liang, T. Zhu, and W. Hang, Zhongguo Yike Daxue Xuebao, 20(4), 257-259 (1991);
181. Chem. Abstr., 115, 247704c (1991).
182. D. J. Dargan, C. B. Galt, and J. H. Subak-Sharpe, J. Gen. Virol., 73, 397-406 (1992).
183. D. J. Dargan, C. B. Galt, and J. H. Subak-Sharpe, J. Gen. Virol., 73, 407-411 (1992).
184. H. G. Jeong and J. Y. Kim, FEBS Lett., 513, 208-212 (2002).
185. G. Lampis, A. Ingianni, and R. Pompei, Antiviral Res., 36, 191-195 (1997).
186. M. Yamamoto, F. Norimitsu, and T. Sakamoto, Jpn. Pat. Appl. No. 1305021 (1989);
187. Ref. Zh. Khim., 20 O 230P (1991).
188. K. Fujisawa, Y. Watanabe, and K. Kimura, Asian Med. J., 23(10), 745-756 (1980).
189. H. Suzuki, Y. Ohta, T. Takino, et al., Asian Med. J., 26(7), 423-438 (1983).
190. S. Iino, T. Tango, T. Matsushima, et al., Hepatol. Res., 19(1), 31-40 (2001).
191. K. Fujisawa, Y. Watanabe, and K. Kimura, Kan, Tan, Sui, 7(3), 369-379 (1983).
192. K. Fujisawa, Y. Watanabe, T. Kitagawa, et al., Shindan to Chiryo, 76(2), 726-732 (1984).
193. S. Fujiyama, H. Chikazawa, Y. Honda, et al., Biother. Jpn., 12, 1495-1513 (1998).
194. Y. Suzuki, K. Ikeda, S. Saitoh, et al., Acta Hepatol. Jpn., 37, 363-367 (1996).
195. T. Okuno, K. Arai, and M. Shindo, Jpn. J. Clin. Med., 53(9), 1022-1025 (1995).
196. Y. Yamamoto, A. Yasuoka, N. Tachikawa, et al., Jpn. J. Infectious Dis., 52(6), 248-249 (1999).
197. A. Tandon, B. N. Tandon, and R. A. Bhujwala, Hepatol. Res., 20, No. 1, 1-8 (2001).
198. R. Segal, S. Pisanty, and E. Azaz, GB Pat. No. 2, 167, 296, May 29, 1986;
199. Chem. Abstr., 106, 55907p (1987).
200. R. Segal, S. Pisanty, and E. Azaz, USA Pat. No. 4, 678, 772 (1988);
201. Ref. Zh. Khim., 17 O 251P (1988).
202. R. Segal, S. Pisanty, and E. Azaz, DE Pat. No. 3, 443, 242, May 28, 1986;
203. Chem. Abstr., 105, 120776r (1986).
204. R. Segal, S. Pisanty, and E. Azaz, Fr. Pat. No. 2, 573, 655 (1986);
205. Ref. Zh. Khim., 14 O 243P (1987).
206. Virucidal Mechanism of Action and Clinical Use [in Russian], Mezhdunarodnyi Mezhakademicheskii Soyuz i AMTN RF, Moscow (2002).
207. V. V. Pomazanov and Yu. V. Koroleva, Glycyrrhizin-contain-ing Preparations - New Effective Agent for Antiviral Therapy [in Russian], AMTN RF, Moscow (2001).
208. A. Gonsales, Prevencion y tratamiento tratammiento antitumoral, antiviral y de otras entermedactes degenerativas, Catalysis, S. L., Madrid (2001), p. 60.
209. Z. H. Hu, Yaoxue Xuebao, 23, No. 7, 553-560 (1988).
210. A. Noirfalise, From Licorice to Glycyrrhizin, Hommage Professeur Rene Truhaut, Fac. Pharm. Univ. Paris, Paris (1984), pp. 818-821.
211. Y. Fan, Z. Shi, and B. He, Tianran Chanwu Yanjiu Yu Kaifa, 8(4), 93-99 (1996);
212. Chem. Abstr., 127, 92647h (1997).